Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28725400 | 0.81 | — | — | |
| SCHEMBL3545881 | 0.80 | POLB (0.31) | — | |
| Hydrochloric Acid SCHEMBL17361360 | 0.74 | — | — | |
| Sulfuric Acid SCHEMBL6390742 | 0.73 | CA12 (0.32) | — | |
| SCHEMBL7400833 | 0.73 | CYP1A2 (0.34) | — | |
| SCHEMBL344424 | 0.73 | — | — | |
| SCHEMBL1646906 | 0.73 | — | — | |
| SCHEMBL26129787 | 0.72 | — | — | |
| SCHEMBL29317119 | 0.71 | NOS3 (0.40) | — | |
| Sulfuric Acid SCHEMBL9355340 | 0.71 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3463354-A1 | USE OF 2-SUBSTITUTED INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF AUTOIMMUNE DISEASES | Bayer Pharma Aktiengesellschaft (DE) | 2019-04-10 | — | — | EP | disclosed |
| EP-3423446-A1 | NEW 2-SUBSTITUTED INDAZOLES, METHODS FOR PRODUCING SAME, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAME, AND USE OF SAME TO PRODUCE DRUGS | Bayer Pharma Aktiengesellschaft (DE) | 2019-01-09 | — | — | EP | disclosed |
| CN-104271574-B | Heterocyclic compounds | 武田药品工业株式会社 | 2017-01-25 | — | — | CN | disclosed |
| CN-104271574-A | Heterocyclic compounds | TAKEDA PHARMACEUTICAL | 2015-01-07 | — | — | CN | disclosed |